Concepedia

David Lee

DL

Statistics

Publications

13

Citations

899

H-Index

13

Active since

1989

Affiliations

Johns Hopkins University(Current)

Albert Einstein College of Medicine

Cornell University

Johns Hopkins Medicine

National Cancer Institute

David Lee is an author at Johns Hopkins University specializing in pharmacology, medicine, and pharmacodynamics of anticancer agents.

ORCID

Publications per year

1989–2018

13

Publications

13

Towards germline gene therapy of inherited mitochondrial diseases

Masahito Tachibana, Paula Amato, Michelle Sparman et al. · Nature · 2012 · 424 citations · Full text

, , +12

Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast Cancer

Joseph A. Sparano, Stacy L. Moulder, Aslamuzzaman Kazi et al. · Clinical Cancer Research · 2009 · 74 citations · Full text

, , +17

Targeted Inhibition of Farnesyltransferase in Locally Advanced Breast Cancer: A Phase I and II Trial of Tipifarnib Plus Dose-Dense Doxorubicin and Cyclophosphamide

Joseph A. Sparano, Stacy L. Moulder, Aslamuzzaman Kazi et al. · Journal of Clinical Oncology · 2006 · 66 citations · Full text

, , +17

Cluster of genes encoding the major egg envelope protein of zebrafish

David E. Mold, Irene F. Kim, Chuan-Mei Tsai et al. · Molecular Reproduction and Development · 2000 · 60 citations

, , +17

Discovery and Optimization of HKT288, a Cadherin-6–Targeting ADC for the Treatment of Ovarian and Renal Cancers

Carl Uli Bialucha, Scott D. Collins, Xiao Li et al. · Cancer Discovery · 2017 · 55 citations · Full text

, , +15

1–5 of 13